The Precision Neuroscience competitor challenging Neuralink through human brain implant testing

In a groundbreaking surgery at The Mount Sinai Hospital in New York City, Dr. Joshua Bederson, system chair for the Department of Neurosurgery at Mount Sinai Health System, made medical history by placing Precision Neuroscience’s electrodes onto a patient’s brain. The procedure, which involved removing a benign brain tumor called meningioma, not only highlighted Bederson’s expertise as a neurosurgeon but also showcased how advancements in science are pushing the boundaries of what is possible in the field of neurology.

Precision Neuroscience is a three-year-old startup that is pioneering the development of a brain-computer interface (BCI) system. This system, known as the Layer 7 Cortical Interface, consists of a microelectrode array with 1,024 electrodes that can conform to the brain’s surface without causing damage. During the surgery in April, Bederson used four of Precision’s arrays to set a record for the highest number of electrodes placed on a brain in real-time. These arrays were able to detect signals from the patient’s individual fingers, providing a level of detail that standard electrodes cannot capture.

The implications of this level of detail are significant. By using Precision’s electrode array, doctors can access a wealth of information that can help them be more precise and delicate in their surgeries and other interventions. For Precision, the ability to record and decode signals from individual fingers is a crucial step toward helping patients with severe paralysis restore functions like speech and movement.

While the data collected from the surgery marks a milestone for Precision, the company still has a long road ahead to achieve its ultimate goals. It is working towards FDA approval for its BCI system and has yet to implant a patient with a more permanent version of its technology. However, the progress made during the surgery at Mount Sinai is a testament to the potential of BCIs in revolutionizing the field of neurology.

As the BCI industry continues to evolve, scientists like Bederson and companies like Precision are at the forefront of unlocking the mysteries of the brain. With advancements in technology and a deeper understanding of neural signals, the future holds immense promise for patients with neurological disorders. The collaboration between academia, health systems, and innovative startups is driving the field forward, paving the way for a new era of personalized and effective treatments for patients in need.

In conclusion, the surgery conducted by Dr. Joshua Bederson and Precision Neuroscience represents a significant milestone in the development of brain-computer interface technology. The successful placement of electrode arrays onto a patient’s brain opens up new possibilities for restoring functions in patients with severe paralysis. As the field of neurology continues to advance, the future looks bright with endless possibilities for improving the quality of life for individuals with neurological disorders.

Back To Top